The University of Chicago Header Logo

Connection

Hedy Kindler to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Poly(ADP-ribose) Polymerase Inhibitors.
Hedy Kindler
Connection Strength
0.814
Poly(ADP-ribose) Polymerase Inhibitors
  1. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Ann Oncol. 2019 12 01; 30(12):1959-1968.
    View in: PubMed
    Score: 0.668
  2. Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. Eur J Cancer. 2018 01; 89:19-26.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.